Action of celgosivir (6 O-butanoyl castanospermine) against the pestivirus BVDV: implications for the treatment of hepatitis C.
about
Design, synthesis, and biological evaluation of antiviral agents targeting flavivirus envelope proteinsCastanospermine, a potent inhibitor of dengue virus infection in vitro and in vivoDiastereoselective nitrenium ion-mediated cyclofunctionalization: total synthesis of (+)-castanospermineNatural products to drugs: natural product-derived compounds in clinical trials.Natural products to drugs: natural product derived compounds in clinical trials.Novel therapies in hepatitis B and C.New drugs for hepatitis C virus.Review article: investigational agents for chronic hepatitis C.New therapeutic approaches to hepatitis C virus.HCV drug discovery aimed at viral eradication.Emerging therapies for hepatitis C virus.Synthesis and biological activity of naturally occurring α-glucosidase inhibitors.Development of novel antiviral therapies for hepatitis C virus.Antiviral therapy for hepatitis C virus: beyond the standard of care.Antiviral drug discovery: broad-spectrum drugs from nature.Synthesis and biological evaluation of N-arylated-lactam-type iminosugars as potential immunosuppressive agents.Inhibition of bovine viral diarrhea virus RNA synthesis by thiosemicarbazone derived from 5,6-dimethoxy-1-indanone.alpha-Glucosidase inhibitors have a prolonged antiviral effect against hepatitis B virus through the sustained inhibition of the large and middle envelope glycoproteins.Future therapies for hepatitis C: where do we go from here?Antiviral Chemistry & Chemotherapy's current antiviral agents FactFile 2008 (2nd edition): RNA viruses.A new approach to 3-hydroxyprolinol derivatives by samarium diiodide-mediated reductive coupling of chiral nitrone with carbonyl compounds.
P2860
Q22570477-16A8EBEF-73E3-484B-8E46-F67C23677068Q24531947-0A301123-1FFD-4F36-8F21-281D1B198F9CQ34306359-E83D18C2-68DB-4F39-A80A-C3999DC9E19BQ34780898-C1E80AD6-7116-4CBB-B81F-6439064DAB43Q36087066-C2EEC522-C834-4DF2-8567-1FA90BBC6573Q37140034-DCF12A6A-FEAC-4ADD-84E9-14B9C9DBE8A5Q37346061-5070C4C6-F101-4179-A643-F7DBB33644F3Q37381744-61E6A456-3E6A-48E6-B865-3A6BE6CC984EQ37489533-F8055A9D-8E27-485B-9EA8-0784990D6FE7Q37664059-B99B032A-D159-4C0A-8950-1AF119796EBAQ37772514-2FF239D1-8007-4474-A799-29E7C87135C5Q37780460-0F818392-4974-4BEC-AE6F-C64E7612D7E7Q37801585-770D2C31-CF5B-4742-AC45-EB313A80A5FCQ37945201-5C02725C-21B4-4B93-A89C-71041BC36E77Q38260235-F7B512B8-5451-4D60-BEE3-5EEA4AA67D1EQ38697382-05AE94F2-EDB3-4ED2-9540-690A4DF63202Q39571877-6A81228F-12EA-4A31-85B8-23A0D2A5D3DAQ40193811-B9572960-A7A7-4F01-8FA1-A1DE313FEE62Q40246585-E867E2AD-7AAA-4F0B-8781-40960FE27237Q42981047-6D9286C3-14BA-4741-8777-6B7A5EDE7C00Q45937568-531675A5-DDA5-41AE-9000-E9D08F90CE3F
P2860
Action of celgosivir (6 O-butanoyl castanospermine) against the pestivirus BVDV: implications for the treatment of hepatitis C.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Action of celgosivir (6 O-buta ...... the treatment of hepatitis C.
@en
type
label
Action of celgosivir (6 O-buta ...... the treatment of hepatitis C.
@en
prefLabel
Action of celgosivir (6 O-buta ...... the treatment of hepatitis C.
@en
P2093
P2860
P1476
Action of celgosivir (6 O-buta ...... the treatment of hepatitis C.
@en
P2093
A Stanley Tyms
Debra Taylor
Dipa Patel
Kevin Whitby
Parvin Ahmed
P2860
P304
P356
10.1177/095632020401500304
P577
2004-05-01T00:00:00Z